✨ Free AI Report
Amyris: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Amyris
Company Research

Amyris: Business Overview, Financials & Competitive Analysis

Amyris scores 7/10 on the AskCyborg Cyborg Score (Solid). Disciplined B2B biotech play leveraging fermentation IP for specialty ingredients with near-term scaling catalysts in emerging market partnerships. Amyris emerged from Chapter 11 restructuring in May 2024 with refocused operations and achieved operational milestones in 2026. Strategic expansion of manufacturing capacity and high-margin partnerships demonstrate recovery trajectory, but recent bankruptcy and.

What is Amyris's industry? Amyris (amyris.com) operates in Biotechnology. AskCyborg classifies Amyris under Biotechnology in its company registry.

Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane. By early 2026 operates as a private, technology-driven provider of sustainable ingredients for f...

7/ 10Solid

Cyborg Score thesis

Disciplined B2B biotech play leveraging fermentation IP for specialty ingredients with near-term scaling catalysts in emerging...

Read the full analyst-debate transcript →
Industry Biotechnology
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Amyris Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Amyris

AskCyborg analysts argue the bull and bear cases for Amyris across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Amyris OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Amyris Overview

Pro stress-test →

Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane. By early 2026 operates as a private, technology-driven provider of sustainable ingredients for flavors, fragrances and cosmetics.

Strategic Profile

Pro stress-test →

Following Chapter 11 in 2024, the firm refocused and divested retail brands. The company is refocusing its strategy on its core B2B ingredients business and aims to leverage its 'Lab-to-Market™' platform for sustainable ingredient manufacturing.

Competitive Landscape

Pro stress-test →

Amyris competes in the specialty biochemical ingredients market against integrated chemical companies and synthetic biology firms. Key competition comes from established specialty chemical manufacturers with existing customer relationships and distribution networks, as well as other precision fermentation platforms pursuing similar ingredient applications.

Industry Context

Amyris operates in Biotechnology.

Key facts

Founded: 2003 · Headquarters: Emeryville, US · Employees: 987 · Revenue: Estimated based on 2025 growth trajectory; private company post-bankruptcy

What the analysts stress-tested

The top findings that survived the multi-agent debate for Amyris.

  • The company plans to bring a fourth fermentation line online in early 2026, which is expected to nearly double the plant's capacity. Doubled capacity underpins revenue scaling targets.
  • WACKER and biomanufacturing pioneer Amyris joined forces in the personal care sector in April 2026, with WACKER contributing formulation expertise while Amyris brings biotechnology and biomanufacturing know-how. Partnership validates market demand.
+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026CEO Kathy Fortmann featured discussing business transformation with renewed operational discipline and B2B focus
  • March 2026New production line at Barra Bonita plant becomes operational; CEO discusses expanded manufacturing capabilities
Get alerted when Amyris has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ginkgo BioworksSynthetic biology platform for bio-based ingredients and specialty chemicals→SolugenCell-free enzyme system for sustainable specialty chemicals→ArzedaSynthetic biology platform engineering enzymes for sustainable ingredient production→

Compare Amyris with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Amyris operates in Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology research →
NEW · MCP server

Ask your AI assistant about Amyris

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Amyris and its top competitor on Cyborg Score”
“What did Amyris do this quarter?”
“Is Amyris a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Amyris do?+
Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane. By early 2026 operates as a private, technology-driven provider of sustainable ingredients for f...
What is Amyris's Cyborg Score?+
Amyris has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Amyris's main competitors?+
Named competitors include Ginkgo Bioworks, Solugen, Arzeda. The full competitive landscape is in the AskCyborg report.
How can I get the full Amyris research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Amyris research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Amyris over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Abivax SA8Bavarian Nordic A/S8Beam Therapeutics Inc.8CG Oncology, Inc.8Cogent Biosciences, Inc.8COMPASS Pathways plc8CSL Limited8Eckert & Ziegler SE8Krystal Biotech, Inc.8Legend BiotechTop companies in Biotechnology by Cyborg Score